VAERS 1736249
GLAXOSMITHKLINE BIOLOGICALS · HEP B (ENGERIX-B) · Charge AN3NC
- Staat
- MS
- Alter
- 30,0
- Geschlecht
- M
- Eingang
- 27.09.2021
- Impfdatum
- 20.09.2021
- Beginn
- 20.09.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Symptomtext
30 male patient received an expired pediatric dose of ENGERIX-B; expired pediatric dose of ENGERIX-B; 30 male patient received an expired pediatric dose of ENGERIX-B; This case was reported by a pharmacist via call center representative and described the occurrence of underdose in a 30-year-old male patient who received HBV (Engerix B pediatric) (batch number AN3NC, expiry date 3rd June 2021) for prophylaxis. Co-suspect products included hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis. On 20th September 2021, the patient received Engerix B pediatric .5 ml and Engerix B Pre-Filled Syringe Device. On 20th September 2021, unknown after receiving Engerix B pediatric and Engerix B Pre-Filled Syringe Device, the patient experienced underdose, expired vaccine used and adult use of a child product. On an unknown date, the outcome of the underdose, expired vaccine used and adult use of a child product were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were reported as follows: Pharmacist reported that a 30 year old male patient received pediatric dose of Engerix B on the 20th September 2021, which got expired on 3rd June 2021, which led to expired vaccine used, adult use of a child product and underdose. No further details were provided at the time of the call. The reporter consented to follow up by email.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -